DCF — JOYCE EISENBERG KEEFER MEDICAL CENTE
Enterprise Value: $33.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$33.7M
Enterprise Value
$8.6M
PV of Cash Flows
$25.1M
PV of Terminal Value
$40.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $54.5M | $4.6M | 9.0% | $1.5M | $1.4M |
| Year 2 | $56.1M | $5.3M | 10.0% | $2.0M | $1.6M |
| Year 3 | $57.8M | $6.1M | 11.0% | $2.5M | $1.9M |
| Year 4 | $59.5M | $6.5M | 11.0% | $2.8M | $1.9M |
| Year 5 | $61.3M | $6.9M | 11.0% | $3.0M | $1.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $33.7M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$52.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0800000007565307
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5